OUE Healthcare Limited (SGX:5WA)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.0250
-0.0010 (-3.85%)
At close: Feb 27, 2026

OUE Healthcare Income Statement

Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
152.39150.28159.32119.819.67
Revenue Growth (YoY)
1.41%-5.67%32.99%509.18%-1.58%
Cost of Revenue
3836.1137.5918.195.09
Gross Profit
114.39114.17121.73101.6114.57
Selling, General & Admin
35.0429.4430.8823.5112.24
Other Operating Expenses
16.7-1.02-2.27-0.54-1.05
Operating Expenses
51.7428.4228.6122.9811.19
Operating Income
62.6585.7593.1278.633.39
Interest Expense
-33.58-28.42-26.55-19.27-3.95
Interest & Investment Income
0.540.680.70.460.26
Earnings From Equity Investments
-6.151.281.69-1.4712.65
Currency Exchange Gain (Loss)
--7.09-3.74-1.1-0.09
EBT Excluding Unusual Items
23.4552.2165.2257.2412.25
Merger & Restructuring Charges
--0.03--0.83-0.75
Gain (Loss) on Sale of Investments
---3.14-
Gain (Loss) on Sale of Assets
--0.2--0.71-
Asset Writedown
--12.699.3-10.13-19.89
Legal Settlements
-1.3-1.026.69
Other Unusual Items
----109.97
Pretax Income
23.4540.5974.5249.74108.28
Income Tax Expense
14.8814.9417.0117.24-2.67
Earnings From Continuing Operations
8.5725.6557.5132.5110.95
Net Income to Company
8.5725.6557.5132.5110.95
Minority Interest in Earnings
-25.45-31.65-49.46-28.10.43
Net Income
-16.87-68.054.39111.38
Net Income to Common
-16.87-68.054.39111.38
Net Income Growth
--83.27%-96.06%-
Shares Outstanding (Basic)
4,4404,4434,4434,4434,443
Shares Outstanding (Diluted)
7,0304,4437,1527,1526,603
Shares Change (YoY)
58.23%-37.87%-8.32%48.60%
EPS (Basic)
-0.00-0.000.000.000.03
EPS (Diluted)
-0.00-0.000.000.000.02
EPS Growth
--83.33%-96.45%-
Free Cash Flow
54.860.1165.0551.013.14
Free Cash Flow Per Share
0.010.010.010.01-
Gross Margin
75.06%75.97%76.41%84.82%74.11%
Operating Margin
41.11%57.06%58.45%65.64%17.23%
Profit Margin
-11.07%-4.00%5.05%3.67%566.38%
Free Cash Flow Margin
35.96%40.00%40.83%42.58%15.95%
EBITDA
65.5986.293.5879.14.27
EBITDA Margin
43.04%57.36%58.74%66.03%21.71%
D&A For EBITDA
2.950.450.460.470.88
EBIT
62.6585.7593.1278.633.39
EBIT Margin
41.11%57.06%58.45%65.64%17.23%
Effective Tax Rate
63.44%36.81%22.82%34.66%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.